Fosaprepitant

Results: 9



#Item
1concentrations of these drugs, potentially causing serious or lifethreatening reactions[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effec

concentrations of these drugs, potentially causing serious or lifethreatening reactions[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effec

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-08-13 14:35:06
2Microsoft Word - EMEND IV_14-01_168157_EN.docx

Microsoft Word - EMEND IV_14-01_168157_EN.docx

Add to Reading List

Source URL: www.merck.ca

Language: English - Date: 2014-09-29 16:29:30
3Microsoft Word - EMEND IV_14-01_168157_EN-CI

Microsoft Word - EMEND IV_14-01_168157_EN-CI

Add to Reading List

Source URL: www.merck.ca

Language: English - Date: 2014-09-29 16:21:37
4MONOGRAPHIE DE PRODUIT  EMEND® IV fosaprépitant pour injection 150 mg de fosaprépitant/flacon (sous forme de fosaprépitant diméglumine)

MONOGRAPHIE DE PRODUIT EMEND® IV fosaprépitant pour injection 150 mg de fosaprépitant/flacon (sous forme de fosaprépitant diméglumine)

Add to Reading List

Source URL: www.merck.ca

Language: French - Date: 2014-09-23 00:54:39
    5IMPORTANT : VEUILLEZ LIRE ATTENTIVEMENT PARTIE III : RENSEIGNEMENTS POUR LE CONSOMMATEUR EMEND® IV fosaprépitant pour injection (sous forme de fosaprépitant diméglumine)

    IMPORTANT : VEUILLEZ LIRE ATTENTIVEMENT PARTIE III : RENSEIGNEMENTS POUR LE CONSOMMATEUR EMEND® IV fosaprépitant pour injection (sous forme de fosaprépitant diméglumine)

    Add to Reading List

    Source URL: www.merck.ca

    Language: French - Date: 2014-09-23 00:28:48
      6Case 3:14-cv[removed]PGS-LHG Document 1 Filed[removed]Page 1 of 31 PageID: 1  Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520

      Case 3:14-cv[removed]PGS-LHG Document 1 Filed[removed]Page 1 of 31 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520

      Add to Reading List

      Source URL: patentdocs.typepad.com

      Language: English - Date: 2014-06-25 05:00:42
      7Proposed Patient Product Information Amendment 08Nov2010 150mg IV

      Proposed Patient Product Information Amendment 08Nov2010 150mg IV

      Add to Reading List

      Source URL: www.merck.com

      Language: English - Date: 2012-07-11 10:15:26
      8concentrations of these drugs, potentially causing serious or lifethreatening reactions[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effec

      concentrations of these drugs, potentially causing serious or lifethreatening reactions[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EMEND safely and effec

      Add to Reading List

      Source URL: www.merck.com

      Language: English - Date: 2014-08-19 07:46:44
      9Journal of Cancer 2014, Vol. 5  Ivyspring

      Journal of Cancer 2014, Vol. 5 Ivyspring

      Add to Reading List

      Source URL: www.jcancer.org

      Language: English - Date: 2014-04-22 19:41:49